2018
DOI: 10.4172/neuropsychiatry.1000479
|View full text |Cite
|
Sign up to set email alerts
|

Determinants of Progression and Mortality in Alzheimers disease: A Systematic Review

Abstract: Neuropsychiatric symptoms (NPS) have been regarded as predictors of poor outcomes, and the use of neuroleptics as well, but with contradictory results. The objective of this article is to perform a systematic review of published works dealing with progression and survival in AD. Methods We searched articles aimed at determining the factors predicting faster cognitive decline and mortality in AD, published from January 1987 to April, 2018. We gave priority to prospective and retrospective cohorts analysing the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
13
0
3

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(20 citation statements)
references
References 75 publications
2
13
0
3
Order By: Relevance
“…Construct validity of the domains was shown through testing of an a priori hypothesis of their association with recognised outcomes. A record of a marker such as psychosis within the Severe Neuropsychiatric domain increased risk of all outcomes, concordant with a previously identified link of behavioural and psychological symptoms and/or antipsychotic use with risk of hospitalisation, nursing home admission, and mortality [28–31]. The Increased Multimorbidity, Comorbidity, and Symptoms domains were commonly recorded and strongly associated with the outcomes, supporting reviews showing increases in comorbidity and health‐related burden related to poor dementia outcomes [30,32,33].…”
Section: Discussionsupporting
confidence: 77%
See 1 more Smart Citation
“…Construct validity of the domains was shown through testing of an a priori hypothesis of their association with recognised outcomes. A record of a marker such as psychosis within the Severe Neuropsychiatric domain increased risk of all outcomes, concordant with a previously identified link of behavioural and psychological symptoms and/or antipsychotic use with risk of hospitalisation, nursing home admission, and mortality [28–31]. The Increased Multimorbidity, Comorbidity, and Symptoms domains were commonly recorded and strongly associated with the outcomes, supporting reviews showing increases in comorbidity and health‐related burden related to poor dementia outcomes [30,32,33].…”
Section: Discussionsupporting
confidence: 77%
“…A record of a marker such as psychosis within the Severe Neuropsychiatric domain increased risk of all outcomes, concordant with a previously identified link of behavioural and psychological symptoms and/or antipsychotic use with risk of hospitalisation, nursing home admission, and mortality [28–31]. The Increased Multimorbidity, Comorbidity, and Symptoms domains were commonly recorded and strongly associated with the outcomes, supporting reviews showing increases in comorbidity and health‐related burden related to poor dementia outcomes [30,32,33]. The Care domain showed associations across all outcomes; research shows that caregiver coping and stress is associated with poor outcomes in the person with dementia [30,34], but also will be reflective of increased provision of care as demonstrated by the strong association with palliative care.…”
Section: Discussionsupporting
confidence: 75%
“…Полученные данные о большей тяжести деменции при первичном обращении и относительном увеличении доли мужчин в завершённых случаях совпадают с прогностическими оценками роли этих факторов при изучении показателей смертности в работах других авторов [18,15].…”
Section: Discussionunclassified
“…Противоречивые результаты получены в отношении применения антипсихотиков у больных деменцией. По данным обзора 42 исследований атипичные антипсихотики не обнаружили влияния на уменьшение сроков дожития, но их применение обнаружило ассоцииацию с более быстрым когнитивным снижением [54].…”
Section: некогнитивные (поведенческие и психопатологические) симптомыunclassified
“…Изложенные в настоящем обзоре результаты изучения влияния отдельных факторов на скорость прогрессирования деменции варьируются от вполне ожидаемых в соответствии с клиническим опытом до значительных расхождений в представлениях, что находит подтверждение в других обзорах и обосновывает необходимость дальнейших многоаспектных клинико-биологических исследований [50,52,54]. Ведение больных деменцией в практике предусматривает учет различных факторов, влияющих на скорость прогрессирования деменции, для планирования объема и характера лечебной помощи.…”
Section: заключениеunclassified